NBR2
gene geneOn this page
Also known as NCRNA00192
Summary
NBR2 (neighbor of BRCA1 lncRNA 2, HGNC:20691) is a long non-coding RNA gene on chromosome 17q21.31.
This gene was identified by its close proximity on chromosome 17 to tumor suppressor gene BRCA1. Experimental evidence indicates that the two genes share a bi-directional promoter. Transcription for either gene is controlled individually by distinct transcriptional repressor factors. A short (112 amino acid) open reading frame is observed which includes a region derived from a LINE1 element. A strong Kozak signal is not observed for the putative ORF and the stop codon is more than 55 nucleotides upstream of the last splice site for the transcript, suggesting that the transcript is subject to nonsense-mediated decay. Therefore, this gene does not appear to encode a protein. Glucose starvation induces the expression of this gene and the long non-coding RNA transcribed by it functions with AMP-activated protein kinase in mediating the energy stress response.
Source: NCBI Gene 10230 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20691 |
| Approved symbol | NBR2 |
| Name | neighbor of BRCA1 lncRNA 2 |
| Location | 17q21.31 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NCRNA00192 |
| Ensembl gene | ENSG00000198496 |
| Ensembl biotype | lncRNA |
| OMIM | 618708 |
| Entrez | 10230 |
| RNAcentral | URS0000A77648 — lncRNA, 1512 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 16 lncRNA
ENST00000356906, ENST00000460115, ENST00000467245, ENST00000657841, ENST00000790195, ENST00000790196, ENST00000790197, ENST00000790198, ENST00000790199, ENST00000790200, ENST00000790201, ENST00000790202, ENST00000790203, ENST00000790204, ENST00000790205, ENST00000790206
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000356906 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001295162 | 43139816 | 43140333 |
| ENSE00002944137 | 43138657 | 43138922 |
| ENSE00003828833 | 43131208 | 43131270 |
| ENSE00004170207 | 43125420 | 43125770 |
Expression profiles
Bgee: expression breadth ubiquitous, 214 present calls, max score 87.29.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.8719 / max 182.2081, expressed in 1798 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161053 | 8.9850 | 1766 |
| 161054 | 6.8869 | 1617 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 87.29 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.99 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.49 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.35 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.68 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 81.58 | gold quality |
| thyroid gland | UBERON:0002046 | 81.07 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 80.88 | gold quality |
| transverse colon | UBERON:0001157 | 80.86 | gold quality |
| right uterine tube | UBERON:0001302 | 80.71 | gold quality |
| secondary oocyte | CL:0000655 | 80.46 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.36 | silver quality |
| right ovary | UBERON:0002118 | 80.10 | gold quality |
| body of stomach | UBERON:0001161 | 79.84 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.69 | gold quality |
| minor salivary gland | UBERON:0001830 | 79.60 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.36 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.27 | gold quality |
| spleen | UBERON:0002106 | 79.18 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.04 | gold quality |
| rectum | UBERON:0001052 | 79.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.97 | gold quality |
| small intestine | UBERON:0002108 | 78.95 | gold quality |
| prostate gland | UBERON:0002367 | 78.91 | gold quality |
| skin of leg | UBERON:0001511 | 78.77 | gold quality |
| body of pancreas | UBERON:0001150 | 78.69 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.65 | gold quality |
| skin of abdomen | UBERON:0001416 | 78.61 | gold quality |
| left ovary | UBERON:0002119 | 78.51 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 78.38 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.33 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 14)
- Data indicate that long non-coding RNAs (lncRNAs) NBR2 (neighbour of BRCA1 gene 2) interacts with AMP-activated kinase (AMPK) and promotes AMPK kinase activity during energy stress. (PMID:26999735)
- Data indicate that long non-coding RNAs (lncRNAs) NBR2 (neighbour of BRCA1 gene 2) modulates cancer cell sensitivity to phenformin through NBR2 regulation of GLUT1 expression at transcriptional level. (PMID:27792451)
- NBR2-GLUT1 axis may serve as an adaptive response in cancer cells to survive in response to phenformin treatment. (PMID:27792451)
- High NBR2 expression is associated with breast cancer. (PMID:28249151)
- data suggested that miR-19a negatively controlled the autophagy of hepatocytes attenuated in D-GalN/LPS-stimulated hepatocytes via regulating NBR2 and AMPK/PPARalpha signaling. (PMID:28586153)
- LncRNA NBR2 inhibits EMT progression by regulating Notch1 pathway in NSCLC. (PMID:31599420)
- This study revealed a novel mechanism by which long noncoding RNA NBR2 mediates curcumin suppression of colorectal cancer proliferation by activating adenosine monophosphate-activated protein kinase and inactivating the mTOR signaling pathway. (PMID:31888414)
- LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. (PMID:33378941)
- LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis. (PMID:33651649)
- NBR2 promotes the proliferation of glioma cells via inhibiting p15 expression. (PMID:34076984)
- Long non-coding RNA NBR2 suppresses the progress of colorectal cancer in vitro and in vivo by regulating the polarization of TAM. (PMID:34506209)
- LncRNA NBR2 Regulates Cancer Cell Stemness and Predicts Survival in Non-small Cell Cancer Patients by Downregulating TGF-beta1. (PMID:35909269)
- NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis. (PMID:35951458)
- Long non-coding RNA NBR2 suppresses the progression of colorectal cancer by downregulating miR-19a to regulate M2 macrophage polarization. (PMID:38149567)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): breast-ovarian cancer, familial, susceptibility to, 1, hereditary breast ovarian cancer syndrome